🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
This phase I/II trial investigates the side effects of genetically engineer...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-07-19
Trial ID
NCT04639245
Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-03-30
Trial ID
NCT05467670
Treatments Being Tested
This is an open-label, single arm Phase II study designed to evaluate the e...
Status
Recruiting
Location
Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
Start Date
2021-01-30
Trial ID
NCT05552846
Treatments Being Tested
This phase II, open-label, dose-escalation study aims to (1) assess the saf...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-09
Trial ID
NCT06858969
Treatments Being Tested
The purpose of this research study is to evaluate the effectiveness of usin...
Status
Active Not Recruiting
Location
Indiana University Simon Comprehensive Cancer Center
Start Date
2022-09-02
Trial ID
NCT05366166
Treatments Being Tested
This is a phase I, open label, plus expansion clinical trial evaluating the...
Status
Recruiting
Location
Children's Health Orange County (CHOC)
Start Date
2022-01-10
Trial ID
NCT04943848
Treatments Being Tested
The recent approval of ICB treatments targeting cytotoxic T-lymphocyte anti...
Status
Unknown
Location
Universitair Ziekenhuis Antwerpen
Start Date
2020-06-06
Trial ID
NCT04860076
Treatments Being Tested
Study Title: A Real-World Study on Extensive-Stage Small Cell Lung Cancer (...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09
Trial ID
NCT07173946
Treatments Being Tested